About us

More than 10 years of expertise in providing tailor-made solutions for the market access and pricing of pharmaceutical products and medical devices.

Early Benefit Assessment and AMNOG Price Negotiations

Full-scale AMNOG support: strategy, dossier, price negotiation, and arbitration. 

European Health Technology Assessment

Strategic advice and EU dossiers in collaboration with our European partner network.

LinkedIn posts around HTA

Ecker + Ecker regularly posts
HTA-related content on LinkedIn. 

Pricing & Reimbursement

Modular tools for the optimization of pricing and reimbursement in the life cycle of a medicinal product.

Statistics for Market Access

Customized statistical evaluation of clinical trials for all questions regarding market access.